Loading…
Searching for genetic determinants for left ventricular non-compaction
Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated wi...
Saved in:
Published in: | Quantitative imaging in medicine and surgery 2024-10, Vol.14 (10), p.7046-7060 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 7060 |
container_issue | 10 |
container_start_page | 7046 |
container_title | Quantitative imaging in medicine and surgery |
container_volume | 14 |
creator | Spałek, Michał Kusińska, Aneta Spałek, Jan Siudak, Zbigniew Wożakowska-Kapłon, Beata Adamus-Białek, Wioletta |
description | Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different
have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria.
We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain (
), α-cardiac actin (
), cardiac troponin T (
), myosin binding protein-C (
), LIM-domain binding protein 3 (
), and taffazin (
).
In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 (
region of
) and rs2675686 (
), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 (
3'UTR), rs3729998 (
. 12), and rs727503240 (
. 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied
region and rs397516254 in exon 39 of the
gene.
To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of S |
doi_str_mv | 10.21037/qims-24-470 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11485346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3118835977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c234t-ae9bb526b89403b5bad031a99c028af3e422739f6cc42f212f93e912106f33183</originalsourceid><addsrcrecordid>eNpVkM1LAzEQxYMottTePMsePbiaZLIfOYkUq0LBg3oO2TRpI7tJm-wW_O_dfqJzmYH3eDPzQ-ia4HtKMBQPa9vElLKUFfgMDSmlkDLA-flxppwO0DjGb9xXUZKC4Es0AN4LWcmGaPqhZVBL6xaJ8SFZaKdbq5K5bnVorJOujTuh1qZNNtq1waquliFx3qXKNyupWuvdFbowso56fOgj9DV9_py8prP3l7fJ0yxVFFibSs2rKqN5VXKGocoqOcdAJOcK01Ia0IzSArjJlWLUUEINB81J_2puAEgJI_S4z111VaPnanuQrMUq2EaGH-GlFf8VZ5di4TeCEFZmwPI-4faQEPy607EVjY1K17V02ndRACFlCRkvit56t7eq4GMM2pz2ECx2-MUWv6BM9Ph7-83f207mI2z4Bc7pgdE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3118835977</pqid></control><display><type>article</type><title>Searching for genetic determinants for left ventricular non-compaction</title><source>PubMed Central</source><creator>Spałek, Michał ; Kusińska, Aneta ; Spałek, Jan ; Siudak, Zbigniew ; Wożakowska-Kapłon, Beata ; Adamus-Białek, Wioletta</creator><creatorcontrib>Spałek, Michał ; Kusińska, Aneta ; Spałek, Jan ; Siudak, Zbigniew ; Wożakowska-Kapłon, Beata ; Adamus-Białek, Wioletta</creatorcontrib><description>Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different
have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria.
We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain (
), α-cardiac actin (
), cardiac troponin T (
), myosin binding protein-C (
), LIM-domain binding protein 3 (
), and taffazin (
).
In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 (
region of
) and rs2675686 (
), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 (
3'UTR), rs3729998 (
. 12), and rs727503240 (
. 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied
region and rs397516254 in exon 39 of the
gene.
To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of SNVs in the
,
,
and
genes segments analyzed. Further studies are required to confirm or exclude "potentially protective" SNV in the 39th exon of
(rs397516254) and the role of co-occurrence of individual SNVs in rs8037241 (
), rs3729998 (
), and rs727503240 (MYH7) for the increase of the risk of LVNC.</description><identifier>ISSN: 2223-4292</identifier><identifier>EISSN: 2223-4306</identifier><identifier>DOI: 10.21037/qims-24-470</identifier><identifier>PMID: 39429584</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Original</subject><ispartof>Quantitative imaging in medicine and surgery, 2024-10, Vol.14 (10), p.7046-7060</ispartof><rights>2024 AME Publishing Company. All rights reserved.</rights><rights>2024 AME Publishing Company. All rights reserved. 2024 AME Publishing Company.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2402-9129</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485346/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485346/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39429584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spałek, Michał</creatorcontrib><creatorcontrib>Kusińska, Aneta</creatorcontrib><creatorcontrib>Spałek, Jan</creatorcontrib><creatorcontrib>Siudak, Zbigniew</creatorcontrib><creatorcontrib>Wożakowska-Kapłon, Beata</creatorcontrib><creatorcontrib>Adamus-Białek, Wioletta</creatorcontrib><title>Searching for genetic determinants for left ventricular non-compaction</title><title>Quantitative imaging in medicine and surgery</title><addtitle>Quant Imaging Med Surg</addtitle><description>Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different
have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria.
We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain (
), α-cardiac actin (
), cardiac troponin T (
), myosin binding protein-C (
), LIM-domain binding protein 3 (
), and taffazin (
).
In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 (
region of
) and rs2675686 (
), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 (
3'UTR), rs3729998 (
. 12), and rs727503240 (
. 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied
region and rs397516254 in exon 39 of the
gene.
To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of SNVs in the
,
,
and
genes segments analyzed. Further studies are required to confirm or exclude "potentially protective" SNV in the 39th exon of
(rs397516254) and the role of co-occurrence of individual SNVs in rs8037241 (
), rs3729998 (
), and rs727503240 (MYH7) for the increase of the risk of LVNC.</description><subject>Original</subject><issn>2223-4292</issn><issn>2223-4306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LAzEQxYMottTePMsePbiaZLIfOYkUq0LBg3oO2TRpI7tJm-wW_O_dfqJzmYH3eDPzQ-ia4HtKMBQPa9vElLKUFfgMDSmlkDLA-flxppwO0DjGb9xXUZKC4Es0AN4LWcmGaPqhZVBL6xaJ8SFZaKdbq5K5bnVorJOujTuh1qZNNtq1waquliFx3qXKNyupWuvdFbowso56fOgj9DV9_py8prP3l7fJ0yxVFFibSs2rKqN5VXKGocoqOcdAJOcK01Ia0IzSArjJlWLUUEINB81J_2puAEgJI_S4z111VaPnanuQrMUq2EaGH-GlFf8VZ5di4TeCEFZmwPI-4faQEPy607EVjY1K17V02ndRACFlCRkvit56t7eq4GMM2pz2ECx2-MUWv6BM9Ph7-83f207mI2z4Bc7pgdE</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Spałek, Michał</creator><creator>Kusińska, Aneta</creator><creator>Spałek, Jan</creator><creator>Siudak, Zbigniew</creator><creator>Wożakowska-Kapłon, Beata</creator><creator>Adamus-Białek, Wioletta</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2402-9129</orcidid></search><sort><creationdate>20241001</creationdate><title>Searching for genetic determinants for left ventricular non-compaction</title><author>Spałek, Michał ; Kusińska, Aneta ; Spałek, Jan ; Siudak, Zbigniew ; Wożakowska-Kapłon, Beata ; Adamus-Białek, Wioletta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c234t-ae9bb526b89403b5bad031a99c028af3e422739f6cc42f212f93e912106f33183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Spałek, Michał</creatorcontrib><creatorcontrib>Kusińska, Aneta</creatorcontrib><creatorcontrib>Spałek, Jan</creatorcontrib><creatorcontrib>Siudak, Zbigniew</creatorcontrib><creatorcontrib>Wożakowska-Kapłon, Beata</creatorcontrib><creatorcontrib>Adamus-Białek, Wioletta</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Quantitative imaging in medicine and surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spałek, Michał</au><au>Kusińska, Aneta</au><au>Spałek, Jan</au><au>Siudak, Zbigniew</au><au>Wożakowska-Kapłon, Beata</au><au>Adamus-Białek, Wioletta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Searching for genetic determinants for left ventricular non-compaction</atitle><jtitle>Quantitative imaging in medicine and surgery</jtitle><addtitle>Quant Imaging Med Surg</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>14</volume><issue>10</issue><spage>7046</spage><epage>7060</epage><pages>7046-7060</pages><issn>2223-4292</issn><eissn>2223-4306</eissn><abstract>Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different
have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria.
We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain (
), α-cardiac actin (
), cardiac troponin T (
), myosin binding protein-C (
), LIM-domain binding protein 3 (
), and taffazin (
).
In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 (
region of
) and rs2675686 (
), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 (
3'UTR), rs3729998 (
. 12), and rs727503240 (
. 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied
region and rs397516254 in exon 39 of the
gene.
To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of SNVs in the
,
,
and
genes segments analyzed. Further studies are required to confirm or exclude "potentially protective" SNV in the 39th exon of
(rs397516254) and the role of co-occurrence of individual SNVs in rs8037241 (
), rs3729998 (
), and rs727503240 (MYH7) for the increase of the risk of LVNC.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>39429584</pmid><doi>10.21037/qims-24-470</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-2402-9129</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2223-4292 |
ispartof | Quantitative imaging in medicine and surgery, 2024-10, Vol.14 (10), p.7046-7060 |
issn | 2223-4292 2223-4306 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11485346 |
source | PubMed Central |
subjects | Original |
title | Searching for genetic determinants for left ventricular non-compaction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A45%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Searching%20for%20genetic%20determinants%20for%20left%20ventricular%20non-compaction&rft.jtitle=Quantitative%20imaging%20in%20medicine%20and%20surgery&rft.au=Spa%C5%82ek,%20Micha%C5%82&rft.date=2024-10-01&rft.volume=14&rft.issue=10&rft.spage=7046&rft.epage=7060&rft.pages=7046-7060&rft.issn=2223-4292&rft.eissn=2223-4306&rft_id=info:doi/10.21037/qims-24-470&rft_dat=%3Cproquest_pubme%3E3118835977%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c234t-ae9bb526b89403b5bad031a99c028af3e422739f6cc42f212f93e912106f33183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3118835977&rft_id=info:pmid/39429584&rfr_iscdi=true |